71
Participants
Start Date
November 30, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
October 31, 2008
Sorafenib
The initial dose of Sorafenib will be administered orally with a dose of 400 mg twice a day, daily. Intrapatient dose escalation will occur as defined in the protocol, providing no dose limiting toxicity (Grade 3 or 4) is observed.
Methodist Hospital - Baylor College of Medicine, Houston